"Every 8 Seconds, Someone Gets a Nosebleed. We Built the Device That Finally Stops Them."
Nosebleeds aren't a minor inconvenience — they're a massive, underserved medical problem.
Epistaxis (nosebleed) affects approximately 1 in 7 people over their lifetime, sending millions to emergency rooms each year at enormous cost to patients and healthcare systems alike. The global epistaxis treatment market was valued at $310 million in 2024 and is projected to grow to $530 million by 2035 — yet the standard of care has barely changed in decades: gauze, packing, and hope.
JStop™ changes that.
JStop™ is a purpose-built, minimally invasive epistaxis device designed to stop severe and chronic nosebleeds quickly, reliably, and without the pain and complexity of traditional nasal packing. By combining targeted inflation and controlled compression directly at the source of bleeding, JStop™ delivers what patients, first responders, and clinicians have been asking for: a device that actually works — every time.
We’re seeking strategic investors who believe that better tools mean better outcomes. Join us in making “all nosebleeds stop” not just a tagline, but a clinical reality.Pitch Deck (click to navigate)
Interested in learning more about our company? Contact us!